HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetsuya Tsukamoto Selected Research

Methylnitronitrosoguanidine (MNNG)

3/2015Preventive effect of rebamipide on N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats.
1/2009Endoscopic observation of N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rat using a newly-developed flexible endoscope.
11/2007Cyclin D1 overexpression in N-methyl-N'-nitro-N-nitrosoguanidine-induced rat gastric adenocarcinomas.
1/2007Effects of eradication of Helicobacter pylori on gastric carcinogenesis in experimental models.
7/2005Whole-genome analyses of loss of heterozygosity and methylation analysis of four tumor-suppressor genes in N-methyl-N'-nitro-N-nitrosoguanidine-induced rat stomach carcinomas.
12/2003beta-Catenin mutations and nuclear accumulation during progression of rat stomach adenocarcinomas.
5/2003Global expression analysis of N-methyl-N'-nitro-N-nitrosoguanidine-induced rat stomach carcinomas using oligonucleotide microarrays.
9/2002Appearance of osteonectin-expressing fibroblastic cells in early rat stomach carcinogenesis and stomach tumors induced with N-methyl-N'-nitro-N-nitrosoguanidine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tetsuya Tsukamoto Research Topics

Disease

48Neoplasms (Cancer)
01/2022 - 04/2002
42Carcinogenesis
12/2020 - 05/2002
37Stomach Neoplasms (Stomach Cancer)
02/2020 - 04/2002
22Infections
02/2022 - 04/2002
16Adenocarcinoma
04/2021 - 05/2002
11Inflammation (Inflammations)
03/2016 - 08/2005
8Carcinoma (Carcinomatosis)
03/2015 - 10/2002
7Gastritis
04/2016 - 04/2008
6Metaplasia
04/2007 - 03/2004
3Colitis
03/2016 - 11/2007
3Adenoma (Adenomas)
01/2016 - 05/2002
3Stress Urinary Incontinence
01/2016 - 08/2015
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
08/2013 - 01/2012
3Infarction (Infarctions)
08/2013 - 01/2012
3Hyperplasia
04/2007 - 05/2002
2COVID-19
12/2022 - 03/2022
2Constipation
08/2021 - 11/2014
2Papillomavirus Infections
01/2021 - 01/2019
2Lymphatic Metastasis
06/2020 - 08/2012
2Wounds and Injuries (Trauma)
01/2019 - 07/2017
2Skin Neoplasms (Skin Cancer)
12/2018 - 10/2006
2Xeroderma Pigmentosum (Kaposi's Disease)
12/2018 - 10/2006
2Ischemic Stroke
08/2013 - 01/2012
2Atrophy
01/2012 - 06/2007
2Carcinoid Tumor (Carcinoid)
01/2009 - 01/2008
2Body Weight (Weight, Body)
11/2007 - 07/2007
2Colorectal Neoplasms (Colorectal Cancer)
12/2003 - 06/2003
1Myocarditis (Carditis)
12/2022
1Adenocarcinoma of Lung
06/2022
1Lung Neoplasms (Lung Cancer)
06/2022
1Hemolysis
03/2022
1Insulinoma
02/2022
1Gastrinoma
02/2022
1Cushing Syndrome
02/2022
1Lymphoma (Lymphomas)
10/2021
1Pathologic Constriction (Stenosis)
08/2021
1Uterine Cervical Dysplasia
01/2021
1Squamous Intraepithelial Lesions
01/2021

Drug/Important Bio-Agent (IBA)

23CarcinogensIBA
08/2017 - 04/2002
10SaltsIBA
07/2013 - 10/2002
10Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
04/2013 - 05/2002
8Methylnitronitrosoguanidine (MNNG)IBA
03/2015 - 09/2002
5CytokinesIBA
01/2021 - 12/2008
5DNA (Deoxyribonucleic Acid)IBA
02/2020 - 06/2004
5Pharmaceutical PreparationsIBA
01/2019 - 10/2009
5Biological ProductsIBA
01/2019 - 04/2002
5Proteins (Proteins, Gene)FDA Link
01/2019 - 12/2003
44-vinyl-2,6-dimethoxyphenolIBA
01/2015 - 04/2008
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2013 - 10/2006
4Transcription Factors (Transcription Factor)IBA
01/2011 - 01/2004
4beta CateninIBA
12/2008 - 12/2003
4MucinsIBA
01/2007 - 10/2005
3A-Form DNA (A-DNA)IBA
06/2022 - 08/2012
3AcidsIBA
02/2020 - 11/2016
3Dextran SulfateIBA
03/2016 - 01/2013
3Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2016 - 08/2015
3N- (7- (1- hydroxyethyl)- 3- (4- isopropylphenyl)- 4,6- dimethyl- 2,3- dihydro- 1- benzofuran- 5- yl)- 3,3- dimethylbutanamideIBA
08/2013 - 01/2012
3GastrinsIBA
01/2011 - 01/2008
3Pepsinogen A (Pepsinogen)IBA
03/2010 - 05/2002
3Bromodeoxyuridine (BrdU)IBA
04/2008 - 03/2006
2Messenger RNA (mRNA)IBA
12/2022 - 01/2019
2Immune Checkpoint InhibitorsIBA
06/2022 - 01/2020
2SteroidsIBA
03/2022 - 11/2014
2Indicators and Reagents (Reagents)IBA
11/2019 - 03/2009
2Phenobarbital (Luminal)FDA Link
01/2019 - 01/2019
2Rad30 proteinIBA
12/2018 - 10/2006
2Dinoprostone (PGE2)FDA Link
01/2015 - 10/2006
2AzoxymethaneIBA
12/2013 - 11/2007
2Cannabinoid Receptor AgonistsIBA
08/2013 - 01/2012
2SolutionsIBA
01/2011 - 10/2006
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
03/2010 - 08/2005
2Etodolac (Lodine)FDA LinkGeneric
03/2010 - 08/2005
2pitavastatin (itavastatin)FDA Link
08/2009 - 11/2007
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2009 - 11/2007
2Drinking WaterIBA
11/2007 - 12/2003
2Cyclin D1IBA
11/2007 - 05/2003
2diisopropanolnitrosamineIBA
10/2007 - 07/2006
2Dimenhydrinate (DMH)FDA LinkGeneric
08/2006 - 06/2003
21,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
08/2006 - 06/2003
2villinIBA
10/2005 - 01/2005
1COVID-19 VaccinesIBA
12/2022
1ParaffinIBA
06/2022
1B7-H1 AntigenIBA
06/2022
1Formaldehyde (Formol)FDA Link
06/2022
1HaptoglobinsIBA
03/2022
1tocilizumab (atlizumab)FDA Link
03/2022
1remdesivirIBA
03/2022
1CEACAM1 ProteinIBA
02/2022
1Adrenocorticotropic Hormone (ACTH)FDA Link
02/2022
1InterferonsIBA
01/2022
1Interleukin-12 (IL 12)IBA
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021
1CurcuminIBA
12/2020

Therapy/Procedure

8Chemoprevention
01/2019 - 08/2005
5Lasers (Laser)
11/2019 - 01/2005
4Therapeutics
01/2020 - 10/2009
2Laparotomy
08/2021 - 07/2015
2Proctectomy
04/2021 - 01/2020
2Gastrectomy
05/2018 - 08/2007
1Pancreaticoduodenectomy
02/2022